Preventive Health Care Use in Elderly Cancer Survivors

老年癌症幸存者的预防保健用途

基本信息

批准号：
7097391
负责人：
ALEXANDER M MCBEAN
金额：
$ 13.49万
依托单位：
UNIVERSITY OF MINNESOTA
依托单位国家：
美国
项目类别：
财政年份：
2004
资助国家：
美国
起止时间：
2004-09-30 至 2008-08-31
项目状态：
已结题

项目摘要

DESCRIPTION (provided by applicant) The high 5-year relative survival rates for many cancer types mean that cancer survivors should receive the recommended clinical preventive services, as well as quality health care for other co-existing chronic diseases. It is important, as well as consistent with the Healthy People 2010 objectives, that older Americans, including those of each race and ethnic group, receive these services irregardless of whether they have survived cancer, or not. This study will test if recommended clinical preventive services, including cancer screening, as well as diabetes quality of care guidelines, are met as frequently among elderly Americans who have survived breast, uterine, colon and rectal, bladder, or prostate cancer as among elderly persons without cancer. The services we will study are (a) influenza immunization; (b) the American Diabetes Association's recommended diabetes quality of care measures: the determination of serum hemoglobin Alc (HbA1 c) and low-density lipids (LDL-C), eye examination, and testing for diabetic nephropathy in persons who have diabetes, and (c) screening for breast, colorectal and prostate cancer. We will study elderly Medicare fee-for-service beneficiaries identified in the Surveillance, Epidemiology and End Results (SEER)-Medicare linked database with incident breast, uterine, colorectal, bladder or prostate cancer who survived 5 to 25 years We will determine the use of appropriate clinical preventive and diabetes care services in the four-year period from January 1, 1998 through December 31, 2001. Specifically, we will (1) compare the rates of utilization of the recommended care in the cancer survivors to the rates in a 5 percent sample of elderly Americans living in SEER areas who have not had cancer; and (2) compare the use of services in the majority population (non-Hispanic whites) with the minority population groups: non-Hispanic blacks, Hispanics and Asians. We will do a sub-set analysis of use of these services among persons who are diagnosed with localized cancer compared with those with regional or distant disease. Important covariates in all analyses include the type(s) of initial treatment received (surgery or radiation), patient sociodemographic variables, comorbidities, and the specialties of the physicians providing care.

描述（由申请人提供）许多癌症类型的高5年相对生存率意味着癌症幸存者应获得推荐的临床预防服务，并为其他共存的慢性疾病提供优质的医疗保健。重要的是，与健康人的2010年目标相一致，包括每个种族和族裔的老年人，都无法获得这些服务，而无需对他们是否在癌症中幸存下来。这项研究将测试如果建议的临床预防服务，包括癌症筛查以及糖尿病的护理质量指南，在乳腺癌，子宫，结肠和直肠，膀胱癌，膀胱癌或前列腺癌中幸存下来的老年美国人与没有癌症的老年人中经常满足。我们将研究的服务是（a）流感免疫；（b）美国糖尿病协会推荐的糖尿病护理质量措施：确定血清血红蛋白ALC（HBA1 C）和低密度脂质（LDL-C），眼睛检查和测试糖尿病患者的糖尿病性肾脏疗法，以及糖尿病和（C）筛选乳腺癌和乳明癌症的糖尿病。我们将研究在监视，流行病学和最终结果（SEER） - Medicare与事件的乳房，子宫，子宫，大肠癌，大肠膀胱或前列腺癌连接到5至25年中的事件，我们将确定适当的临床预防和糖尿病护理期间的使用时间为1月1日，在1月1日1月1日，在5到25年中，我们将在5至25年中生存下来，从而在5至25年中生存下来。比较癌症幸存者推荐护理的利用率与居住在没有癌症的塞尔地区的5％样本中的5％样本中；（2）比较多数人口（非西班牙裔白人）中的服务使用与少数人口群体：非西班牙裔黑人，西班牙裔和亚洲人。与区域或远处疾病的人相比，我们将对被诊断为局部癌症的人进行这些服务的使用分析。所有分析中的重要协变量包括接受的初始治疗（手术或辐射）的类型，患者社会人口统计学变量，合并症以及提供护理的医生的专业。